Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and efficacy of FOLFIRI (Irinotecan,
Leucovorin and 5 Fluorouracil) chemotherapy when combined with sunitinib or FOLFIRI
chemotherapy without adding sunitinib as the first line treatment of patients with metastatic
colorectal cancer.